As Medicare prepares to negotiate drug prices directly with pharma companies, the White House has selected 10 drugs that make up 20% — one-fifth — of Medicare’s annual spending. Our analysis provides a deep dive into these drugs, including their costs, the number of enrollees depending on them and the significant price hikes since their…